224 related articles for article (PubMed ID: 32308544)
21. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
[TBL] [Abstract][Full Text] [Related]
22. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
Ullah M; Eucker J; Sittinger M; Ringe J
Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
[TBL] [Abstract][Full Text] [Related]
24. Intracellular expression profile and clinical significance of the CCR9-CCL25 chemokine receptor complex in nasopharyngeal carcinoma.
Ye LF; Huang J; Zhang LP; Chen Z
J Laryngol Otol; 2015 Oct; 129(10):1013-9. PubMed ID: 26279399
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
26. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
[TBL] [Abstract][Full Text] [Related]
27. CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks.
Spinnen J; Ringe J; Sittinger M
Regen Med; 2018 Oct; 13(7):833-844. PubMed ID: 30284497
[TBL] [Abstract][Full Text] [Related]
28. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
29. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
[TBL] [Abstract][Full Text] [Related]
30. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
[TBL] [Abstract][Full Text] [Related]
31. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
[TBL] [Abstract][Full Text] [Related]
32. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression.
Liu C; Qiang J; Deng Q; Xia J; Deng L; Zhou L; Wang D; He X; Liu Y; Zhao B; Lv J; Yu Z; Lei QY; Shao ZM; Zhang XY; Zhang L; Liu S
Cancer Res; 2021 Dec; 81(23):5919-5934. PubMed ID: 34580061
[TBL] [Abstract][Full Text] [Related]
33. The Clinical Significance of Cancer Stem Cell Markers ALDH1A1 and CD133 in Lung Adenocarcinoma.
Miyata T; Oyama T; Yoshimatsu T; Higa H; Kawano D; Sekimura A; Yamashita N; So T; Gotoh A
Anticancer Res; 2017 May; 37(5):2541-2547. PubMed ID: 28476825
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-130-5p promotes invasion as well as migration of lung adenocarcinoma cells by targeting the EZH2 signaling pathway.
Zhang G; Wu YJ; Yan F
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9480-9488. PubMed ID: 31773700
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia differently regulates the proportion of ALDH
Liu N; Zheng Q; Zhang Y; Wang H; Zhang Z; He L; Wei C; Xia H; Liu Y; Wang X
Thorac Cancer; 2024 Jun; 15(18):1419-1428. PubMed ID: 38736300
[TBL] [Abstract][Full Text] [Related]
36. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9
Chen H; Cong X; Wu C; Wu X; Wang J; Mao K; Li J; Zhu G; Liu F; Meng X; Song J; Sun X; Wang X; Liu S; Zhang S; Yang X; Song Y; Yang YG; Sun T
Sci Adv; 2020 Jan; 6(5):eaax4690. PubMed ID: 32064335
[TBL] [Abstract][Full Text] [Related]
38. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
[TBL] [Abstract][Full Text] [Related]
40. Chemokine (C-C motif) ligand 25 expressed by trophoblast cells and leukocytes bearing its receptor Ccr9: An alliance during embryo implantation?
Weingrill RB; Hoshida MS; Martinhago CD; Correa-Silva S; Cardoso E; Palmeira P; Marinho CRF; Bevilacqua E
Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29154408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
